Cutaneous infection by Scedosporium apiospermum and its successful treatment with itraconazole

Clinical and Experimental Dermatology

Volumn 22, Issue 4, 1997, Pages 198-200

  Liu, Y F ^a,b   Zhao, X D ^a   Ma, C L ^a   Li, C X ^a   Zhang, T S ^a   Liao, W J ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b Broadwalk Offices   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; ISONIAZID; ITRACONAZOLE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; ASCOMYCETES; CASE REPORT; ERYTHEMA; FUNGUS CULTURE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SKIN BIOPSY; SKIN GRANULOMA; SKIN INFECTION; SKIN TUBERCULOSIS; TREATMENT OUTCOME;

EID: 0030776104     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2230.1997.tb01062.x     Document Type: Article

References (9)

1. Bloom PA, Laidlaw DAH, Easty DL, et al. Treatment failure in a case of fungal keratitis caused by Pseudallescheria boydii. Br J Ophthalmol 1992; 76: 367-8.
2. Saccardo PA. In notae mycologicae. Ann Mycol 1911; 9: 254-5.
3. Benham RW, George LK. Allescheria boydii causative agent in a case of meningitis.. J Invest Dermatol 1948; 10: 99-110.
4. Kwon-Chung KJ, Bennet JE. Pseudallescheriasis and. Scedosporium infection. In: Medical Mycology, 1st edn. London: Philadelphia, 1992: 687-94.
5. Galgiani JN. Pseudallescheria boydii infections treated with ketoconazole. Chest 1984; 86: 219-24.
6. Goldberg SL. Successful treatment of simultaneous pulmonary Pseudallescheria boydii and Aspergillus terrens infection with oral itraconazole. Clin Infect Dis 1993; 16: 803-5.
7. Riper JP. Successful treatment of Scedosporium apiospermum suppurative arthritis with itraconaxole. Pediatr Infect Dis J 1990; 9: 674-5.
8. Pether JV. Acute pyogenic Pseudallescheria boydii foot infection sequentially treated with miconazole and itraconazole. J Infect 1992; 25: 335-6.
9. Phillips P. Disseminated infection with Pseudallescheria boydii in a patient with chronic granulomatous disease: response to gamma-interferon plus antifungal chemotherapy. Pediatr Infect Dis J 1991; 10: 536-9.